Plain-English translation of NCT06565637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a 14-session therapy program called PRIDE that combines proven eating disorder treatment techniques with approaches that address the specific challenges LGBTQ+ individuals face. The program focuses on both the eating disorder symptoms themselves and the stress related to discrimination and minority identity that research shows can make eating disorders worse in this population.
LGBTQ+ individuals are 2-3 times more likely to develop eating disorders than others, largely due to discrimination and stress related to their sexual identity. Even though current eating disorder treatments help about half of patients, there are no treatments specifically designed to address the extra stressors that LGBTQ+ patients face, and LGBTQ+ individuals drop out of treatment more often than others.
You likely qualify if…
You likely don't qualify if…
You would participate in 14 therapy sessions conducted online via webcam with a trained therapist. The sessions combine standard eating disorder treatment (such as keeping food logs and addressing concerns about weight and shape) with discussions about how discrimination and minority stress affect your eating and body image, plus skills for coping with this stress. The entire treatment would take place over several months, and you would complete the program from home.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States